Pharma Market Access Insights - from Mtech Access

0
Life Sciences #211

We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Petauri Evidence. 

More
Recent Episodes
  • Communicating value to US Payers: Insights for Pharma and Medtech
    Apr 29, 2025 – 59:02
  • Navigating market access: Launch strategies and health economic modelling for medical devices
    Apr 24, 2025 – 44:41
  • Navigating US payer evidence needs to optimise market access
    Nov 27, 2024 – 57:34
  • Best practice RWE approaches to support economic modelling for HTA
    Nov 20, 2024 – 59:53
  • NHS winter planning 2024–25 – Engaging with NHS decision-makers through Autumn to Christmas
    Nov 18, 2024 – 01:02:50
  • De-mystifying the NHS – What you need to know about the NHS as a market for your health technology
    Oct 11, 2024 – 56:15
  • NHS primary care panel – the GP Contract and Operational Planning Guidance
    Sep 10, 2024 – 01:02:14
  • Engage NHS healthcare decision-makers with RWD
    Aug 12, 2024 – 20:55
  • Market access and reimbursement in Canada – changes at CADTH
    Jun 20, 2024 – 47:43
  • Rare Disease market access in the MENA and Nordic regions
    May 10, 2024 – 59:10
  • How does funding flow in NHSE Regions?
    Apr 9, 2024 – 01:00:15
  • NHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024)
    Apr 9, 2024 – 01:02:06
  • De-mystifying health economic model classifications and structures
    Mar 22, 2024 – 01:00:28
  • Evidence strategy for Medical Technologies and Diagnostics
    Mar 12, 2024 – 53:24
  • How to set your Pharma or Medtech product up for success in the US market
    Feb 26, 2024 – 43:06
  • What's happening with specialised commissioning in the NHS?
    Feb 12, 2024 – 01:00:08
  • Integrated care in NHS Wales – what can England learn from its neighbour?
    Jan 17, 2024 – 56:24
  • Market access in Italy: Reforms at AIFA
    Dec 18, 2023 – 43:36
  • Unmet need in NHS primary care – How can industry best support PCN leaders?
    Nov 28, 2023 – 01:00:44
  • Population health management: a community effort across health and life sciences
    Nov 1, 2023 – 01:04:01
  • Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access
    Oct 26, 2023 – 39:54
  • 6 areas of UK health policy for Medtech to pay attention to
    Oct 16, 2023 – 01:01:49
  • Market access in the German speaking markets
    Aug 29, 2023 – 57:59
  • The role of nursing in driving digital change in the NHS
    Jul 26, 2023 – 54:50
  • Market access for digital therapies and digital medicines
    Jul 19, 2023 – 42:18
  • A global market access journey in cannabinoid pharmaceuticals
    Jun 17, 2023 – 53:47
  • Primary Care and ICBs – what is the next step in the integration journey?
    May 15, 2023 – 01:01:17
  • Data-led transformation in the NHS - partnering to optimise patient care
    Mar 31, 2023 – 01:02:35
  • Innovating for better health – research, collaboration and innovation in the NHS
    Mar 7, 2023 – 57:56
  • Healthcare, economics and society – unlocking NHS collaboration
    Jan 30, 2023 – 59:23
  • Specialised Commissioning in the NHS – What do you need to know now
    Jan 13, 2023 – 01:00:34
  • Why are we waiting? - Pressures facing the NHS and how to deliver change
    Nov 29, 2022 – 01:00:47
  • Priority setting in primary care - NHS insights
    Oct 18, 2022 – 59:35
  • Integrated Care Systems go live in the NHS - reflections after 3 weeks
    Aug 9, 2022 – 01:00:21
  • Clinical Pharmacists – exploring the scope, capabilities, and potential of this evolving NHS role
    Aug 1, 2022 – 01:00:46
  • Transforming systems and care pathways for an integrated NHS
    Jun 21, 2022 – 01:00:47
  • Digital value payer communication tools: How to meet the needs of your internal stakeholders and customers
    May 4, 2022 – 39:25
  • Population to Person: How will the NHS translate population health management into impactful, person-centred service change?
    Mar 15, 2022 – 56:04
  • Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges?
    Feb 11, 2022 – 59:25
  • The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion
    Jan 17, 2022 – 01:02:57
  • Optimising the NHS – How will medicines be valued in integrated systems?
    Dec 21, 2021 – 54:03
  • Rare disease market access - strategic and tactical challenges facing orphan medicines entering Europe
    Nov 29, 2021 – 01:00:49
  • A new paradigm for the NHS: Partnering to deliver lasting and meaningful care improvements - with Dr Phil Webb (Chief Executive of Respiratory Innovation Wales)
    Oct 1, 2021 – 59:33
  • Innovations to address health inequalities in the NHS and how Pharma and Medtech can help
    Sep 10, 2021 – 59:29
  • The hidden heroes of the NHS - The role of ambulance Trusts in keeping patients and systems moving
    Jul 6, 2021 – 59:55
  • Population to person - How will the voice of the individual drive health and care development?
    Jun 2, 2021 – 01:01:57
  • Know your Place - where will power really sit in the new NHS - with Dr Steven Michael OBE
    May 17, 2021 – 01:01:12
  • Health Economic Modelling for MedTech Innovation - What, Why and How
    Apr 14, 2021 – 01:00:34
  • Pharmacy, Medicines, and Specialised Commissioning in the new NHS
    Apr 12, 2021 – 58:29
  • The White Paper and integrated care in the NHS: What it really means in practice for clinicians, patients and us - with Dr John Ribchester
    Mar 11, 2021 – 52:53
Recent Reviews
Disclaimer: The podcast and artwork on this page are property of the podcast owner, and not endorsed by UP.audio.